SCHEMBL28504240

SCHEMBL28504240

CN1CCN(CC(=O)N(C)c2ccc(Br)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
MAPT P10636 2/20 0.52
DRD4 P21917 1/20 0.50
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MELK Q14680 6/20 0.47
CHEK1 O14757 2/20 0.47
PRKAB2 O43741 2/20 0.47
NUAK1 O60285 2/20 0.47
MAPK1 P28482 2/20 0.47
PRKAG1 P54619 2/20 0.47
PRKAA2 P54646 2/20 0.47
PRKAA1 Q13131 2/20 0.47
CAMKK2 Q96RR4 2/20 0.47
PRKAG3 Q9UGI9 2/20 0.47
PRKAG2 Q9UGJ0 2/20 0.47
PRKAB1 Q9Y478 2/20 0.47
ALDH1A1 P00352 3/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8256016 0.87 LMNA (0.52) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL436539 0.85 DRD4 (0.50) LMNAMAPTDRD4RAB9ANPC1
SCHEMBL12359040 0.85 DRD4 (0.67) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL30860308 0.84 MELK (0.54) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL22567606 0.84 DRD4 (0.55) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL20710180 0.83 DRD4 (0.51) LMNAMAPTDRD4RAB9ANPC1
SCHEMBL13227073 0.83 HPGD (0.51) LMNAMAPTDRD4RAB9ANPC1
SCHEMBL13808932 0.82 DRD4 (0.47) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL1361808 0.81 ALDH1A1 (0.50) LMNADRD4RAB9ANPC1SMN1; SMN2
SCHEMBL4490990 0.81 DRD4 (0.46) LMNADRD4RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed